GNPX - Genprex expands clinical trial sites for study to treat small cell lung cancer April, 03 2024 08:46 AM Genprex Inc. 2024-04-03 08:46:01 ET More on Genprex Genprex to effect 1-for-40 reverse stock split to regain Nasdaq compliance Seeking Alpha’s Quant Rating on Genprex Historical earnings data for Genprex Financial information for Genprex For further details see: Genprex expands clinical trial sites for study to treat small cell lung cancer